Trump Win Boosts Insurers, Ratchets Up Expectations for Deals

What You Need To Know

• The new administration is likely to pull back on Biden-era measures affecting health insurers, drug prices and public-health leadership.
• Shares of insurers focused on Medicare have jumped on the expectation that the government will pay higher rates to firms that provide private versions of the health program for seniors.
• Meanwhile, shares of insurers that sell private versions of Medicaid fell on concerns that the next administration will pull back on funding.